Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist
Date
Wed, Jul 22, 2020, 04:00 AM
Full Article
More than 30 states have enacted laws mandating use of prescription drug monitoring programs (PDMP) to reduce inappropriate opioid prescribing. Clinicians in those states must check the PDMP database before writing opioid prescriptions. These mandates vary substantially across states in their timing and scope; for example, some exempt patients with cancer. We examine the association between state mandatory-access PDMPs and changes in the percent of oncologists’ Medicare patients with any opioid prescription fills.
Recommended for you
post
Unveiling the Future of Healthcare with CHIME's AI Principles
Jul 30, 2024
CHIME's AI Principles serve as a beacon, promoting patient safety, administrative efficiencies, regulatory oversight, innovation, and equity.
audio
From Chaos to Clarity: Data Strategies for Scalable AI in Healthcare
Apr 08, 2025
This episode covers the evolving role of AI and data infrastructure in healthcare, the importance of building robust, scalable data foundations before implementing AI, and advanced analytics to ensure measurable outcomes.
post
CHIME Responds to RFI from E&C Privacy Working Group
Apr 07, 2025
CHIME responds to a request for information from a privacy working group led by Energy and Commerce Committee Chairman Brett Guthrie and Vice Chairman John Joyce.
post
Connecting the Dots: Infrastructure in the Age of Hyperconnected Care Delivery
Apr 04, 2025
This roundtable of experts discussed how to address some of the most pressing challenges in infrastructure development, including deciding on hosting options, addressing gaps in connectivity for remote patient care, and planning for a device-driven future in the hospital and in the community.